IRMD
IRADIMED CORP
+0.53 (+0.64%)83.11USD38.7K成交股數1.1B市值46.4本益比(近四季)12.3股價營收比+0.3%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 20.5M+0% | 22.0M+13% | 22.7M+24% | 21.2M+18% | 20.4M+16% | 19.5M+12% | 18.3M+11% | 17.9M+11% | 17.6M | 17.5M | 16.5M | 16.1M |
| 營業成本 | 5.3M | 5.2M | 5.7M | 4.7M | 4.5M | 4.7M | 4.1M | 3.9M | 4.2M | 4.0M | 3.7M | 3.9M |
| 毛利 | 15.2M-5% | 16.8M+13% | 17.0M+20% | 16.5M+18% | 16.0M+19% | 14.8M+11% | 14.2M+11% | 14.0M+15% | 13.4M | 13.4M | 12.8M | 12.2M |
| 毛利率 | 74.1% | 76.5% | 75.1% | 77.8% | 78.2% | 76.1% | 77.4% | 78.1% | 76.1% | 76.9% | 77.8% | 75.5% |
| 研發費用 | 657K | 956K | 800K | 674K | 877K | 624K | 639K | 801K | 821K | −1.6M | 453K | 962K |
| 銷售管理費用 | 3.9M | 4.6M | 4.5M | 4.4M | 4.3M | 4.6M | 4.0M | 4.1M | 4.0M | 4.3M | 3.6M | 3.3M |
| 營業利益 | 6.4M-6% | 7.2M+33% | 7.1M+23% | 6.8M+21% | 6.8M+43% | 5.4M+5% | 5.8M-2% | 5.6M+13% | 4.7M | 5.2M | 5.9M | 5.0M |
| 營業利益率 | 31.2% | 32.9% | 31.3% | 32.2% | 33.3% | 27.8% | 31.6% | 31.4% | 27.0% | 29.6% | 35.8% | 30.8% |
| 稅後淨利 | 5.2M-10% | 5.8M+24% | 6.4M+28% | 5.6M+14% | 5.8M+40% | 4.7M+3% | 5.0M-0% | 4.9M+17% | 4.1M | 4.5M | 5.1M | 4.2M |
| 淨利率 | 25.5% | 26.5% | 28.4% | 26.3% | 28.3% | 24.0% | 27.6% | 27.3% | 23.5% | 26.0% | 30.7% | 25.9% |
| 稀釋 EPS | 0.41-9% | 0.45+22% | 0.50+25% | 0.43+13% | 0.45+41% | 0.37+6% | 0.400% | 0.38+15% | 0.32 | 0.35 | 0.40 | 0.33 |
| 稀釋股數 | 12.9M | 12.9M | 12.9M | 12.9M | 12.8M | 12.8M | 12.8M | 12.8M | 12.7M | 12.7M | 12.7M | 12.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 59.1M | 56.4M | 51.2M | 56.5M | 53.0M | 50.3M | 51.7M | 48.5M | 45.1M | 49.8M | 46.7M | 45.8M |
| 應收帳款 | 13.2M | 13.4M | 13.7M | 13.9M | 10.9M | 12.7M | 10.4M | 12.0M | 13.0M | 12.2M | 12.8M | 11.1M |
| 存貨 | 12.3M | 11.9M | 11.6M | 11.7M | 11.2M | 10.6M | 11.3M | 12.1M | 12.7M | 12.8M | 11.7M | 8.4M |
| 總資產 | 115M | 114M | 109M | 115M | 106M | 102M | 94.2M | 89.9M | 88.0M | 92.2M | 87.4M | 81.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 13.2M | 15.9M | 14.2M | 16.4M | 12.1M | 11.7M | 10.8M | 10.3M | 11.9M | 20.7M | 12.8M | 12.4M |
| 股東權益 | 102M | 98.5M | 94.6M | 98.4M | 94.3M | 90.1M | 83.4M | 79.7M | 76.1M | 71.4M | 74.6M | 69.0M |
| 負債比 | 11.5% | 13.9% | 13.0% | 14.3% | 11.4% | 11.5% | 11.5% | 11.4% | 13.5% | 22.5% | 14.7% | 15.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 8.3M+93% | – | – | – | 4.3M | – | – | 3.9M | – | – | – |
| 資本支出 | – | 403K | – | – | – | 3.7M | – | – | 271K | – | – | – |
| 自由現金流 | – | 7.9M+1226% | – | – | – | 595K | – | – | 3.6M | – | – | – |
| 折舊攤銷 | – | 455K | – | – | – | 194K | – | – | 226K | 256K | 165K | 162K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | 2.6M | – | – | – | 2.2M | – | – | 8.0M | – | – | – |
| 自由現金流率 | – | 35.9% | – | – | – | 3.0% | – | – | 20.5% | – | – | – |
營收拆解 2017 年度 10-K 的分部揭露 · 年增對前一年度
地區2017 年度 · 23.1M
| 美國 | 19.5M | 84.5% | -32.5% |
|---|---|---|---|
| 國際 | 3.6M | 15.5% | -0.4% |
產品／服務2017 年度 · 23.1M
| MRI Compatible IV Infusion Pumps | 13.6M | 59.0% | -46.6% |
|---|---|---|---|
| Disposable IV Sets And Services | 7.6M | 33.0% | +13.4% |
| Mri Compatible Patient Vital Signs Monitoring Systems | 1.8M | 8.0% | +529.7% |
| Devices 小計 | 15.5M | 67.0% | -40.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 83.8M | +14.4% | 22.5M | 26.8% | 1.75 | 17.2M |
| FY2024 | 73.2M | +11.7% | 19.2M | 26.3% | 1.50 | 17.6M |
| FY2023 | 65.6M | +23.0% | 17.2M | 26.2% | 1.35 | 6.0M |
| FY2022 | 53.3M | +27.5% | 12.8M | 24.1% | 1.02 | 9.2M |
| FY2021 | 41.8M | +31.8% | 9.3M | 22.3% | 0.74 | 10.8M |
| FY2020 | 31.7M | -17.7% | 1.4M | 4.3% | 0.11 | 5.4M |
| FY2019 | 38.5M | +26.5% | 9.6M | 25.0% | 0.78 | 9.9M |
| FY2018 | 30.4M | – | 6.3M | 20.7% | 0.52 | 7.1M |